But what if scientists finally figured out how to flip the switch on dormant hair follicles—and actually get them growing ...

Viltrox has announced a new normal prime with a fast F1.4 aperture for Sony E and Nikon Z mount full-frame cameras.

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

Apple is positioning this as the top tablet to buy if you're looking to use AI tools like image-generation apps.